Somatostatin, Substance P and [Lys]-Vasopressin Interfere with the Binding of [3H][D-Ala2, Met5]Enkephalinamide to Rat Brain Membranes
Open Access
- 1 January 1985
- journal article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 38 (4) , 445-447
- https://doi.org/10.1254/jjp.38.445
Abstract
Somatostatin and substance P (10(-6)-3 X 10(-5) M) inhibited dose-dependently the specific binding of [3H] [D-Ala2, Met5]enkephalinamide [( 3H]-DALAMID) to rat brain membranes, by decreasing the number of binding sites. [Lys]-Vasopressin also inhibited the binding, by affecting both the number of binding sites and the affinity of receptors to [3H]DALAMID. The results indicate that somatostatin and substance P may interfere with the endorphin system by an apparently competitive manner.Keywords
This publication has 5 references indexed in Scilit:
- Vasopressin-Induced Antinociception: An Investigation into Its Physiological and Hormonal Basis*Endocrinology, 1983
- Role of disulphide and sulphydryl groups in clustering of enkephalin receptors in neuroblastoma cellsNature, 1979
- Substance P: Characteristics of binding to synaptic vesicles of rat brainNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Somatostatin and ACTH are peptides with partial antagonist-like selectivity for opiate receptorsEuropean Journal of Pharmacology, 1976
- The isolation and characterization of acetylcholine-containing particles from brainBiochemical Journal, 1959